178 related articles for article (PubMed ID: 21782057)
1. Molecular pathogenesis of mantle cell lymphoma: new perspectives and challenges with clinical implications.
Navarro A; Royo C; Hernández L; Jares P; Campo E
Semin Hematol; 2011 Jul; 48(3):155-65. PubMed ID: 21782057
[TBL] [Abstract][Full Text] [Related]
2. Advances in the understanding of mantle cell lymphoma.
Jares P; Campo E
Br J Haematol; 2008 Jun; 142(2):149-65. PubMed ID: 18410453
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of mantle-cell lymphoma: all oncogenic roads lead to dysregulation of cell cycle and DNA damage response pathways.
Fernàndez V; Hartmann E; Ott G; Campo E; Rosenwald A
J Clin Oncol; 2005 Sep; 23(26):6364-9. PubMed ID: 16155021
[TBL] [Abstract][Full Text] [Related]
4. The complex landscape of genetic alterations in mantle cell lymphoma.
Royo C; Salaverria I; Hartmann EM; Rosenwald A; Campo E; Beà S
Semin Cancer Biol; 2011 Nov; 21(5):322-34. PubMed ID: 21945515
[TBL] [Abstract][Full Text] [Related]
5. Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics.
Jares P; Colomer D; Campo E
Nat Rev Cancer; 2007 Oct; 7(10):750-62. PubMed ID: 17891190
[TBL] [Abstract][Full Text] [Related]
6. Molecular biology of mantle cell lymphoma: from profiling studies to new therapeutic strategies.
Obrador-Hevia A; Fernández de Mattos S; Villalonga P; Rodríguez J
Blood Rev; 2009 Sep; 23(5):205-16. PubMed ID: 19362399
[TBL] [Abstract][Full Text] [Related]
7. Genomic profiling of mantle cell lymphoma.
Menanteau MR; Martinez-Climent JA
Methods Mol Biol; 2013; 973():147-63. PubMed ID: 23412788
[TBL] [Abstract][Full Text] [Related]
8. Histopathology of mantle cell lymphoma.
Klapper W
Semin Hematol; 2011 Jul; 48(3):148-54. PubMed ID: 21782056
[TBL] [Abstract][Full Text] [Related]
9. Role of SOX11 and Genetic Events Cooperating with Cyclin D1 in Mantle Cell Lymphoma.
Beà S; Amador V
Curr Oncol Rep; 2017 Jun; 19(6):43. PubMed ID: 28466437
[TBL] [Abstract][Full Text] [Related]
10. A case of hairy cell leukemia with CCND1-IGH@ translocation: indolent non-nodal mantle cell lymphoma revisited.
Chen D; Ketterling RP; Hanson CA; Colgan JP; Zent CS; Viswanatha DS
Am J Surg Pathol; 2011 Jul; 35(7):1080-4. PubMed ID: 21677543
[TBL] [Abstract][Full Text] [Related]
11. Incidence and prognostic impact of secondary cytogenetic aberrations in a series of 145 patients with mantle cell lymphoma.
Espinet B; Salaverria I; Beà S; Ruiz-Xivillé N; Balagué O; Salido M; Costa D; Carreras J; Rodríguez-Vicente AE; Luís García J; Hernández-Rivas JM; Calasanz MJ; Siebert R; Ferrer A; Salar A; Carrió A; Polo N; García-Marco JA; Domingo A; González-Barca E; Romagosa V; Marugán I; López-Guillermo A; Millá F; Luís Mate J; Luño E; Sanzo C; Collado R; Oliver I; Monzó S; Palacín A; González T; Sant F; Salinas R; Ardanaz MT; Font L; Escoda L; Florensa L; Serrano S; Campo E; Solé F
Genes Chromosomes Cancer; 2010 May; 49(5):439-51. PubMed ID: 20143418
[TBL] [Abstract][Full Text] [Related]
12. Blastic mantle cell leukemia: an unusual presentation of blastic mantle cell lymphoma.
Viswanatha DS; Foucar K; Berry BR; Gascoyne RD; Evans HL; Leith CP
Mod Pathol; 2000 Jul; 13(7):825-33. PubMed ID: 10912944
[TBL] [Abstract][Full Text] [Related]
13. Coexistence of BCL1/CCND1 and CMYC aberrations in blastoid mantle cell lymphoma: a rare finding associated with very poor outcome.
Michaux L; Wlodarska I; Theate I; Stul M; Scheiff JM; Deneys V; Ferrant A; Hagemeijer A
Ann Hematol; 2004 Sep; 83(9):578-83. PubMed ID: 15138714
[TBL] [Abstract][Full Text] [Related]
14. Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma.
Dreyling MH; Bullinger L; Ott G; Stilgenbauer S; Müller-Hermelink HK; Bentz M; Hiddemann W; Döhner H
Cancer Res; 1997 Oct; 57(20):4608-14. PubMed ID: 9377576
[TBL] [Abstract][Full Text] [Related]
15. Real-time RT-PCR assay for quantifying cyclin D1 mRNA in B-cell non-Hodgkin's lymphomas.
Medeiros LJ; Hai S; Thomazy VA; Estalilla OC; Romaguera J; Luthra R
Mod Pathol; 2002 May; 15(5):556-64. PubMed ID: 12011261
[TBL] [Abstract][Full Text] [Related]
16. Molecular Pathogenesis of Mantle Cell Lymphoma.
Navarro A; Beà S; Jares P; Campo E
Hematol Oncol Clin North Am; 2020 Oct; 34(5):795-807. PubMed ID: 32861278
[TBL] [Abstract][Full Text] [Related]
17. The pathologic diagnosis of mantle cell lymphoma.
Li S; Xu J; You MJ
Histol Histopathol; 2021 Oct; 36(10):1037-1051. PubMed ID: 34114641
[TBL] [Abstract][Full Text] [Related]
18. CD5-undetected by immunohistochemistry, t(11;14)(q13;q32)-positive conjunctival mantle cell lymphoma: a case report.
Yoo SB; Kim YA; Jeon YK; Kim CW
Pathol Res Pract; 2008; 204(10):779-83. PubMed ID: 18572329
[TBL] [Abstract][Full Text] [Related]
19. Differential effect of epigenetic alterations and genomic deletions of CDK inhibitors [p16(INK4a), p15(INK4b), p14(ARF)] in mantle cell lymphoma.
Hutter G; Scheubner M; Zimmermann Y; Kalla J; Katzenberger T; Hübler K; Roth S; Hiddemann W; Ott G; Dreyling M
Genes Chromosomes Cancer; 2006 Feb; 45(2):203-10. PubMed ID: 16258956
[TBL] [Abstract][Full Text] [Related]
20. Four human t(11;14)(q13;q32)-containing cell lines having classic and variant features of Mantle Cell Lymphoma.
Tucker CA; Bebb G; Klasa RJ; Chhanabhai M; Lestou V; Horsman DE; Gascoyne RD; Wiestner A; Masin D; Bally M; Williams ME
Leuk Res; 2006 Apr; 30(4):449-57. PubMed ID: 16183118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]